Evidence map›Paper›PMID 37918001›Full record

ArticleThe American journal of tropical medicine and hygiene2023

Evaluation of the Performance of a 3D-Printed Smartphone-Based Retinal Imaging Device as a Screening Tool for Retinal Pathology in Mozambique.

Rosauro Varo, María Postigo, Rubao Bila, Elena Dacal, Hélio Chiconela, Jaime García-Villena, Daniel Cuadrado, Alexander Vladimirov, Nuria Díez, Ramón Vallés-López and 13 more

Open access · greenAbstract read
In one paragraph

Article in The American journal of tropical medicine and hygiene, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Digital Technology: Opportunity or Challenge?The American journal of tropical medicine and hygiene · 2024
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors at 7 institutions in 2 countries.

Rosauro VaroISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain.
María PostigoSpotLab, Madrid, Spain.
Rubao BilaCentro de Investigação em Saúde de Manhiça, Maputo, Mozambique.
Elena DacalSpotLab, Madrid, Spain.
Hélio ChiconelaCentro de Investigação em Saúde de Manhiça, Maputo, Mozambique.
Jaime García-VillenaSpotLab, Madrid, Spain.
Daniel CuadradoSpotLab, Madrid, Spain.
Alexander VladimirovSpotLab, Madrid, Spain.
Nuria DíezSpotLab, Madrid, Spain.
Ramón Vallés-LópezSpotLab, Madrid, Spain.
Antonio SitoeCentro de Investigação em Saúde de Manhiça, Maputo, Mozambique.
Pio VitorinoCentro de Investigação em Saúde de Manhiça, Maputo, Mozambique.
Campos MucasseCentro de Investigação em Saúde de Manhiça, Maputo, Mozambique.
Laura Beltran-AgulloInstitut Català de Retina, Barcelona, Spain.
Olivia PujolInstitut Català de Retina, Barcelona, Spain.
Virginia GarcíaInstitut Català de Retina, Barcelona, Spain.
Mariamo AbdalaDepartamento de Oftalmologia, Hospital Central de Maputo, Maputo, Mozambique.
Lucía SalléBiomedical Image Technologies Group, Departamento de Ingeniería Electrónica, Escuela Técnica Superior de Ingenieros Telecomunicación, Universidad Politécnica de Madrid, Madrid, Spain.
Alfonso AntonInstitut Català de Retina, Barcelona, Spain.
Andrés SantosBiomedical Image Technologies Group, Departamento de Ingeniería Electrónica, Escuela Técnica Superior de Ingenieros Telecomunicación, Universidad Politécnica de Madrid, Madrid, Spain.
María J Ledesma-CarbayoBiomedical Image Technologies Group, Departamento de Ingeniería Electrónica, Escuela Técnica Superior de Ingenieros Telecomunicación, Universidad Politécnica de Madrid, Madrid, Spain.
Miguel Luengo-OrozSpotLab, Madrid, Spain.
Quique BassatISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain.
Manhiça Health Research Centre · MZInstitut Català de Retina · ESUniversidad Politécnica de Madrid · ESBarcelona Institute for Global Health · ESInstituto de Salud Carlos III · ESMaputo Central Hospital · MZVall d'Hebron Hospital Universitari · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Low-income countries carry approximately 90% of the global burden of visual impairment, and up to 80% of this could be prevented or cured. However, there are only a few studies on the prevalence of retinal disease in these countries. Easier access to retinal information would allow differential diagnosis and promote strategies to improve eye health, which are currently scarce. This pilot study aims to evaluate the functionality and usability of a tele-retinography system for the detection of retinal pathology, based on a low-cost portable retinal scanner, manufactured with 3D printing and controlled by a mobile phone with an application designed ad hoc. The study was conducted at the Manhiça Rural Hospital in Mozambique. General practitioners, with no specific knowledge of ophthalmology or previous use of retinography, performed digital retinographies on 104 hospitalized patients. The retinographies were acquired in video format, uploaded to a web platform, and reviewed centrally by two ophthalmologists, analyzing the image quality and the presence of retinal lesions. In our sample there was a high proportion of exudates and hemorrhages-8% and 4%, respectively. In addition, the presence of lesions was studied in patients with known underlying risk factors for retinal disease, such as HIV, diabetes, and/or hypertension. Our tele-retinography system based on a smartphone coupled with a simple and low-cost 3D printed device is easy to use by healthcare personnel without specialized ophthalmological knowledge and could be applied for the screening and initial diagnosis of retinal pathology.

Indexed as

Retinal DiseasesSmartphoneHumansMass ScreeningMozambiquePilot ProjectsPrinting, Three-Dimensional

Identifiers

PMID37918001
PMCPMC10622463
OpenAlexW4387447228

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.